Premium
Treatment of suction termination of pregnancy‐retained products with misoprostol markedly reduces the repeat operation rate
Author(s) -
CHAMBERS Dennis G.,
MULLIGAN Ea C.
Publication year - 2009
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.2009.01043.x
Subject(s) - medicine , misoprostol , suction , curettage , pregnancy , dilation and curettage , vacuum aspiration , obstetrics , abortion , surgery , research methodology , family planning , population , mechanical engineering , genetics , environmental health , engineering , biology
A six‐year audit of clinical outcomes following the treatment of suction termination of pregnancy‐retained products of conception symptoms with 200 µg of misoprostol orally or sublingually three times a day for six doses showed that it was 93% effective and it reduced the repeat dilation and curettage rate by 79.6% ( P < 0.001).